Synergistic Effect of Functionalized Nickel Nanoparticles and Quercetin on Inhibition of the SMMC-7721 Cells Proliferation
© to the authors 2009
Received: 27 June 2009
Accepted: 7 August 2009
Published: 23 August 2009
The effect of functionalized nickel (Ni) nanoparticles capped with positively charged tetraheptylammonium on cellular uptake of drug quercetin into hepatocellular carcinoma cells (SMMC-7721) has been explored in this study via microscopy and electrochemical characterization as well as MTT assay. Meanwhile, the influence of Ni nanoparticles and/or quercetin on cell proliferation has been further evaluated by the real-time cell electronic sensing (RT-CES) study. Our observations indicate that Ni nanoparticles could efficiently improve the permeability of cancer cell membrane, and remarkably enhance the accumulation of quercetin in SMMC-7721 cells, suggesting that Ni nanoparticles and quercetin would facilitate the synergistic effect on inhibiting proliferation of cancer cells.
KeywordsNickel nanoparticles Real-time cell electronic sensing (RT-CES) study MTT assay Electrochemical analysis Hepatocellular carcinoma cell line
With the development of nanotechnology, nanomaterials are now widely produced and applied in biomedical and biologic engineering [1–4]. Due to their unique characteristics, nanomaterials and nanotechnologies are changing many basic scientific concepts in a great variety of fields, and are receiving intensively increasing interest in the relative research and industrial applications.
It is well known that the efficiency of many conventional pharmaceutical therapies can be significantly improved through the drug delivery system (DDS). DDS could be designed to alter the pharmacokinetics and biodistribution of their associated drugs and/or to function as drug reservoirs . Some biocompatible nanoparticles, such as gold nanoparticles, iron oxide nanoparticles, have been used in DDS because of their feasibility to produce, characterize, and specifically tailor their functional properties [6–9].
Flavonoids are plant metabolites that are dietary antioxidants and exert significant antiallergic and antiviral effects. Quercetin is one of the most abundant flavonoids in the human diet and has been associated with a large number of biologic activities, many of which may contribute to the prevention of human diseases due to their effects of antihypertensive, antiinflammatory, and anticardiovascular disease [10–13]. Recently, an increasing number of reports have shown that quercetin has multiple effects on cancer cells, which can induce the apoptosis of cancer cells to exert the antitumor effect [14–16]. Additionally, the electrochemical assays for quercetin have been extensively studied due to its sensitive electroactive property [17–20]. Based on these observations, in this study we have utilized electrochemical strategy in the quantitative analysis of quercetin in the cellular systems; meanwhile, the relevant effects of functionalized nickel (Ni) nanoparticles on cellular uptake of drug quercetin into SMMC-7721 cancer cells have also been explored by means of atomic force microscopy (AFM), fluorescence microscopy and electrochemical assay. The result of our studies has afforded the first evidence that the functionalized Ni nanoparticles capped with positively charged tetraheptylammonium could improve the permeability of hepatocellular carcinoma cell membrane, and remarkably enhance the accumulation of quercetin in SMMC-7721 cells.
Meanwhile, the real-time cell electronic sensing (RT-CES) assay also provides the dynamic information that could be used to identify the interaction between cells and chemicals. The RT-CES array has proven valuable, sensitive and reliable for real time monitoring of dynamic changes induced by cell–chemical interaction [21–23]. During the RT-CES assay, the electrode sensor array was specially designed and integrated onto the bottom of a standard microtiter plate and cells directly grow on the sensor surface. The basic principle of the RT-CES system is to monitor the changes in electrode impedance induced by the interaction between testing cells and electrodes, where the presence of the cells will lead to an increase in the electrode impedance. The more cells attached to the sensor, the higher the impedance that could be monitored with RT-CES. Because the test is labeling free and quantitative, the RT-CES assay allows real-time, automatically and continually monitoring cellular status changes during the whole process of the cell–chemical interaction. Accordingly, in this study we have combined the MTT (3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide) assay with RT-CES study . Initially, we have explored the in vitro effect of quercetin in the absence and presence of Ni nanoparticles on SMMC-7721 cancer cells (a hepatocellular carcinoma cell line) by MTT assay, while the dynamic response of cancer cells exposure to Ni nanoparticles and/or quercetin has been determined by the RT-CES system. Our results demonstrate that Ni nanoparticles can readily facilitate the cellular drug uptake of quercetin into cancer cells and enhance the cytotoxicity suppression of quercetin on the proliferation of cancer cells, indicating their great potential in clinical and biomedical applications.
Preparation and Characterization of Ni Nanoparticles
SMMC-7721 cancer cells (purchased from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences) were maintained in RPMI-1640 medium (Gibco, USA) supplemented with 10% fetal bovine serum (Sigma, USA), 100 U/ml penicillin (Sigma, USA), and 100 μg/ml streptomycin (Sigma, USA), and grown at 37 °C in a 5% CO2humidified environment.
Morphological Assay of Cells Treated with Ni Nanoparticles
The SMMC-7721 cells were plated on coverlips in 6-well plates (105cells/well) and treated with different concentration of Ni nanoparticles. The concentrations of Ni nanoparticles cocultured with cells for optical microscopy assay were 3.12, 12.5 and 50 μg/mL, respectively, and cultured in the incubator for 72 h at 37 °C with 5% CO2; while the concentration of Ni nanoparticles cocultured with cells for AFM assay was 12.5 μg/mL and incubated for 6 h at 37 °C with 5% CO2. After treatment, the cells were observed by optical microscopy (Olympus BX 51, Japan) and atomic force microscopy (AFM, SPI 3800N, Japan).
Olympus IX71 Inverted Fluorescence Microscopy
The experiment was performed as described in the literature . The SMMC-7721 cells were seeded on the coverlips in 6-well plates (105 cells/well) and cultured for 24 h at 37 °C with 5% CO2, then both quercetin and Ni nanoparticles were injected to cells and their concentrations were 5.0 and 2.0 μg/mL, respectively. Meanwhile, the cells treated with the same concentration of quercetin were taken as control experiments. All specimens were subsequently incubated for 1 h at 37 °C with 5% CO2, quickly washed with PBS, and then was followed by fixation with 4% formaldehyde for 5 min. Finally, specimens were observed by inverted fluorescence microscopy (Olympus IX71, Japan).
SMMC-7721 cell suspensions (8 × 105cells/mL) containing 50 μmol/L of quercetin were cultured in the absence and presence of 2.0 μg/mL of Ni nanoparticles at room temperature (22 ± 2 °C) for 2 and 6 h, respectively. All samples were diluted with sterile phosphate buffer saline (PBS, 100 mmol/L, pH 7.2). The electrochemical signal was determined with differential pulse voltammetry (DPV) assay for each sample by CHI660C electrochemical analyzer. All measurements were carried out in a three-component electrochemical cell consisting of a glassy carbon electrode as the working electrode, a Pt wire as the counter electrode and a saturated calomel electrode as the reference electrode.
The effect of different quercetin concentrations on SMMC-7721 cancer cells in the absence and presence of Ni nanoparticles was carried out by MTT assay. The final concentrations of quercetin and Ni nanoparticles were 25 (or 50) and 2.0 μg/mL, respectively. Initially, 1 × 104cells were seeded into each well containing 200 μL cell culture medium in 96-well plates and incubated for 24 h, then the relevant chemicals were added and incubated at 37 °C with 5% CO2for 72 h. Controls were cultivated under the same condition without addition of quercetin and/or the Ni nanoparticles. The relevant experiments were repeated thrice independently. The inhibition efficiency (%) was expressed as follows: (1−[A]test/[A]control) × 100, where [A]testand [A]controlrepresent the optical density at 540 nm for the test and control experiments, respectively.
In vitro RT-CES Cytotoxicity Assay
The cell culture condition, the starting cell number and cell culture medium volume used for the 16× sensor device were similar to that of MTT assay. About 50 μmol/L of quercetin in the absence and presence of 2.0 μg/mL of Ni nanoparticles were seeded in the plate. The relevant controls were also seeded in the same plate simultaneously. Once the cells were added to the sensor wells, the sensor devices were placed into the incubator and the real-time cell index (CI) data acquisition was initiated by the RT-CES analyzer (ACEA Bioscience. Inc., USA).
Data were expressed as the means ± SD (standard deviation) from at least three independent experiments. One-tailed unpaired Student’st-test was used for significance testing, andp < 0.05 is considered significant.
Results and Discussion
The Cellular Microscopical Morphology
Enhanced uptake of quercetin by Ni nanoparticles—Fluorescence and electrochemical study
Meanwhile, our electrochemical studies also provide the fresh evidence for the remarkable enhancement effect of the Ni nanoparticles in the drug uptake of quercetin in cancer cells. It is already known that quercetin (i.e., 3,3′,4′,5-7-pentahydroxyflavone), a chemical cousin of the glycoside rutin, is a unique flavonoid that has been extensively studied for its multiple effects as anticancer drug. In the present study, we have utilized the differential pulse voltammetry (DPV) to explore the effect of quercetin alone and quercetin in the presence of Ni nanoparticles on the drug uptake of relevant cancer cells. It is observed that with the anticancer drug quercetin as the electrochemical probe, the drug uptake efficiency for different cancer cells could be probed by the differential pulse voltammetry (DPV) technique. As we know, when different cells treated with quercetin, the unadsorbed drug molecules are still in the environmental solution, and the electrochemical response of this part of the molecules can be readily detected. Thus, the quercetin residue (unadsorbed quercetin) can be adopted as the referential value of the cellular uptake efficiency.
After adding the Ni nanoparticles, apparently more considerable changes of the electrochemical response of quercetin residue outside SMMC-7721 cells were observed than that in the absence of Ni nanoparticles, suggesting that much more quercetin molecules could be diffused into the relative cancer cells in the presence of Ni nanoparticles, which demonstrated that Ni nanoparticles can efficiently enhance the permeation and uptake of quercetin into SMMC-7721 cancer cells.
The rational behind this may be attributed to that the functionalized Ni nanoparticles could efficiently improve the penetration of the drug quercetin into the cell membrane, i.e., appropriate concentration of Ni nanoparticles can effectively facilitate the permeation and uptake of quercetin and increase the accumulation of quercetin in cancer cells. Hence, it appears that when SMMC-7721 cells incubated with quercetin exposed to Ni nanoparticles, it shows greatly efficient quercetin uptake via introduction by functionalized Ni nanoparticles.
Unlike traditional end-point assays the RT-CES readout of impedance is non-invasive and could continuously and quantitatively provide a dynamic measurement of the cytotoxic activity. The time resolution in the assay processes provides high content information regarding the extent of the cytotoxicity in addition to the exact time, while the cytotoxicity takes place at different effect to ratio. Cell Index (CI) is used to represent cell status based on the measured electrical impedance . The calculation of frequency dependent electrode impedance with or without cells present in the wells and corresponding CI value has been described in the literature . In general, under the same physiologic conditions, CI value depends on the number of cells attached to the electrodes: If no cells are present on the electrodes, CI value is 0. The more cells attached to the electrodes (e.g., an increase in cell adhesion or cell spread), the higher the CI value obtained. All the factors that affect the number of cells will result in the change in CI value, e.g., cell proliferation will induce more cells to attach to the sensors and lead to a higher CI value. On the other hand, cell death or toxicity induced cell detachment will result in a lower CI value.
In summary, in this study the cellular effect and in vitro cytotoxicity of SMMC-7721 cancer cells treated with anticancer agents accompanying with functionalized Ni nanoparticles capped with positively charged tetraheptylammonium have been investigated. The morphologies of SMMC-7721 cancer cells in response to various treatments have been explored by microscopy techniques. The enhancement effect of these Ni nanoparticles on the drug uptake of quercetin on SMMC-7721 cancer cells has been observed and their relevant effects on cell proliferation have been evaluated by MTT and RT-CES assay. The results suggest that Ni nanoparticles and quercetin have synergic effect on SMMC-7721 cells, and Ni nanoparticles can efficiently enhance the permeation and uptake of quercetin into cancer cells, implying the great potential of Ni nanoparticles in cancer biomedical and chemotherapeutic applications.
We gratefully acknowledge the support from the National Natural Science Foundation of China (90713023, 20675014, 20535010), National Basic Research Program of China (No. 2010CB732404), Ministry of Science & Technology of China (2007AA022007), and the Natural Science Foundation of Jiangsu Province (BK2008149).
- Kamat PV: Chem. Rev.. 1993, 93: 267. COI number [1:CAS:528:DyaK3sXmvFOnsA%3D%3D] COI number [1:CAS:528:DyaK3sXmvFOnsA%3D%3D] 10.1021/cr00017a013View Article
- Lewis LN: Chem. Rev.. 1993, 93: 2693. COI number [1:CAS:528:DyaK3sXmsFOhs7Y%3D] COI number [1:CAS:528:DyaK3sXmsFOhs7Y%3D] 10.1021/cr00024a006View Article
- Lin XM, Sorensen CM, Klabunde KJ, Hadjipanayis GC: Langmuir. 1998, 14: 7140. COI number [1:CAS:528:DyaK1cXntlansr8%3D] COI number [1:CAS:528:DyaK1cXntlansr8%3D] 10.1021/la980509wView Article
- Wang G, Huang T, Murray RW, Menard L, Nuzzo RG: J. Am. Chem. Soc.. 2005, 127: 812. COI number [1:CAS:528:DC%2BD2MXkvVOmsQ%3D%3D] COI number [1:CAS:528:DC%2BD2MXkvVOmsQ%3D%3D] 10.1021/ja0452471View Article
- Allen TM, Cullis PR: Science. 2004, 303: 1818. COI number [1:CAS:528:DC%2BD2cXitFehu70%3D]; Bibcode number [2004Sci...303.1818A] COI number [1:CAS:528:DC%2BD2cXitFehu70%3D]; Bibcode number [2004Sci...303.1818A] 10.1126/science.1095833View Article
- Everts M, Saini V, Leddon JL, Kok RJ, Stoff-Khalili M, Preuss MA, Millican CL, Perkins G, Brown JM, Bagaria H, Nikles DE, Johnson DT, Zharov VP, Curiel DT: Nano. Lett.. 2006, 6: 587. COI number [1:CAS:528:DC%2BD28Xit1OrsLs%3D]; Bibcode number [2006NanoL...6..587E] COI number [1:CAS:528:DC%2BD28Xit1OrsLs%3D]; Bibcode number [2006NanoL...6..587E] 10.1021/nl0500555View Article
- Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V: Mol. Pharm.. 2005, 2: 194. COI number [1:CAS:528:DC%2BD2MXjtl2jt7Y%3D] COI number [1:CAS:528:DC%2BD2MXjtl2jt7Y%3D] 10.1021/mp0500014View Article
- Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, Hoebeke J, Duguet E, Colombo P, Couvreur P: Bioconjugate Chem.. 2005, 16: 1181. COI number [1:CAS:528:DC%2BD2MXpsleqsrs%3D] COI number [1:CAS:528:DC%2BD2MXpsleqsrs%3D] 10.1021/bc050050zView Article
- Tiefenauer LX, Kuhne G, Andres RY: Bioconjugate Chem.. 1993, 4: 347. COI number [1:CAS:528:DyaK3sXlslKktrY%3D] COI number [1:CAS:528:DyaK3sXlslKktrY%3D] 10.1021/bc00023a007View Article
- Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A: Br. J. Pharmacol.. 2001, 133: 117. COI number [1:CAS:528:DC%2BD3MXjs1ais70%3D] COI number [1:CAS:528:DC%2BD3MXjs1ais70%3D] 10.1038/sj.bjp.0704064View Article
- Formica JV, Regelson W: Food Chem. Toxicol.. 1995, 33: 1061. COI number [1:CAS:528:DyaK28Xht1Cgsw%3D%3D] COI number [1:CAS:528:DyaK28Xht1Cgsw%3D%3D] 10.1016/0278-6915(95)00077-1View Article
- Hertog MGL, Holland PCH: Eur. J. Clin. Nutr.. 1996, 50: 63. COI number [1:STN:280:DyaK283hvFeitQ%3D%3D] COI number [1:STN:280:DyaK283hvFeitQ%3D%3D]
- Yeon JK, Yong CB, Kuen TS, Jin SJ: Biochem. Pharmacol.. 2006, 72: 1268. 10.1016/j.bcp.2006.08.021View Article
- Huang SL, Hsu CL, Yen GC: Life Sci.. 2006, 79: 203. COI number [1:CAS:528:DC%2BD28XkvVGis7k%3D] COI number [1:CAS:528:DC%2BD28XkvVGis7k%3D] 10.1016/j.lfs.2005.12.046View Article
- Kang TB, Liang NC: Biochem. Pharmacol.. 1997, 54: 1013. COI number [1:CAS:528:DyaK2sXntFelt7Y%3D] COI number [1:CAS:528:DyaK2sXntFelt7Y%3D] 10.1016/S0006-2952(97)00260-8View Article
- Tan WF, Lin LP, Li MH, Zhang YX, Tong TG, Xiao D: Eur. J. Pharmacol.. 2003, 459: 255. COI number [1:CAS:528:DC%2BD3sXotVGh] COI number [1:CAS:528:DC%2BD3sXotVGh] 10.1016/S0014-2999(02)02848-0View Article
- Ana MO, Victor CD: Bioelectrochemistry. 2004, 64: 133. 10.1016/j.bioelechem.2004.05.003View Article
- Ana MO, Victor CD: Bioelectrochemistry. 2004, 64: 143. 10.1016/j.bioelechem.2004.05.002View Article
- Howard PH, Arlen DK, Craig EL: J. Pharmaceut. Biomed. Anal.. 1994, 12: 325. 10.1016/0731-7085(94)90007-8View Article
- Kilmartin PA, Zou H, Waterhouse AL: J. Agric. Food. Chem.. 2001, 49: 1957. COI number [1:CAS:528:DC%2BD3MXhs1ymsrk%3D] COI number [1:CAS:528:DC%2BD3MXhs1ymsrk%3D] 10.1021/jf001044uView Article
- Xing JZ, Zhu LJ, Gabos S, Xie L: Toxicol. In Vitro. 2006, 20: 995. COI number [1:CAS:528:DC%2BD28Xmt1Oru70%3D] COI number [1:CAS:528:DC%2BD28Xmt1Oru70%3D] 10.1016/j.tiv.2005.12.008View Article
- Xing JZ, Zhu L, Jackson JA, Gabos S, Sun XJ, Wang XB, Xu X: Chem. Res. Toxicol.. 2005, 18: 154. COI number [1:CAS:528:DC%2BD2MXps1Ogtw%3D%3D] COI number [1:CAS:528:DC%2BD2MXps1Ogtw%3D%3D] 10.1021/tx049721sView Article
- Zhu J, Wang XB, Xu X, Abassi YA: J. Immunol. Methods. 2006, 309: 25. COI number [1:CAS:528:DC%2BD28XhtlGmsLY%3D] COI number [1:CAS:528:DC%2BD28XhtlGmsLY%3D] 10.1016/j.jim.2005.10.018View Article
- Mossman TJ: Immunol. Methods. 1983, 65: 55. 10.1016/0022-1759(83)90303-4View Article
- Guo D, Wu C, Li X, Jiang H, Wang X, Chen B: J. Nanosci. Nanotechnol.. 2008, 8: 2301. COI number [1:CAS:528:DC%2BD1cXmslWru78%3D] COI number [1:CAS:528:DC%2BD1cXmslWru78%3D] 10.1166/jnn.2008.311View Article
- Nifli AP, Theodoropoulos PA, Munier S, Castagnino C, Roussakis E, Katerinopoulos HE, Vercauteren J, Castanas E: J. Agric. Food. Chem.. 2007, 55: 2873. COI number [1:CAS:528:DC%2BD2sXjsVOrsLo%3D] COI number [1:CAS:528:DC%2BD2sXjsVOrsLo%3D] 10.1021/jf0632637View Article
- Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X, Balogh L, Orr BG, Baker JR, Holl MB: Bioconjugate Chem.. 2004, 15: 774. COI number [1:CAS:528:DC%2BD2cXlsF2isbg%3D] COI number [1:CAS:528:DC%2BD2cXlsF2isbg%3D] 10.1021/bc049962bView Article
- Hong S, Leroueil PR, Janus EK, Peters JL, Kober MM, Islam MT, Orr BG, Baker JR, Holl MB: Bioconjugate Chem.. 2006, 17: 728. COI number [1:CAS:528:DC%2BD28XktVSksr0%3D] COI number [1:CAS:528:DC%2BD28XktVSksr0%3D] 10.1021/bc060077yView Article
- Mecke A, Lee DK, Ramamoorthy A, Orr BG, Holl MB: Biophys. J.. 2005, 89: 4043. COI number [1:CAS:528:DC%2BD2MXhtlWms77K] COI number [1:CAS:528:DC%2BD2MXhtlWms77K] 10.1529/biophysj.105.062596View Article